Clinical Trials Sponsored by Edgardo Szyld

Total 498 results

Edgardo Szyld
University of Alabama at Birmingham

Completed

Newborn Ventilation in the Delivery Room: Could it be Improved With a T-piece Resuscitator?

Resuscitation

United States, Argentina, Chile, Italy, Peru
Ospedale Edoardo Bassini

Completed

PENG and LFCN Block Versus FIC Block for Multimodal Analgesia After Total Hip Replacement Surgery: a Retrospective Analysis (PENG+LFCN-FICB)

Regional Anesthesia Morbidity | Arthropathy of Hip | Hip Arthropathy

Italy
Fundación Eduardo Anitua

Active, not recruiting

Randomized Clinical Trial to Evaluate the Predictability of 5.5 mm Dental Implants

Partial-edentulism

Spain
Fundación Eduardo Anitua

Active, not recruiting

Extra-short vs. Non-extra-short Dental Implants Splinted on the Same Prosthesis

Partial-edentulism

Spain
Fundación Eduardo Anitua

Completed

Plasma Rich in Growth Factors (PRGF-Endoret) in the Regeneration of Post-Extraction Sockets

Post-Extraction Sockets Healing

Spain
Ospedale Edoardo Bassini

Recruiting

Comparison of PENG Associated With LFCN Block Versus FICB for Multimodal Analgesic Management in THA

Post Operative Pain | Regional Anesthesia Morbidity | Arthropathy of Hip | Hip Arthropathy | Anesthesia Complication

Italy
Fundación Eduardo Anitua

Recruiting

Plasma Rich in Growth Factors in the Preservation of the Alveolar Ridge After Simple Molar Tooth Extractions.

Dental Implantation

Spain
Ospedale Edoardo Bassini

Not yet recruiting

PENG and LFCN Block Versus FIC Block for Multimodal Analgesia After Total Hip Replacement Surgery: a Retrospective Analysis Focused on Movement (Retro-PvF) (Retro-PvF)

Regional Anesthesia | Regional Anesthesia Block | Total Hip Replacement Surgery | Total Hip Arthroplasty \(THA\)
Fundación Eduardo Anitua

Not yet recruiting

Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva (PRGF)

Lichen Sclerosus of Vulva
Fundación Eduardo Anitua

Recruiting

Randomized Clinical Trial, Conventional Treatment-controlled, Studying the Efficacy of Plasma Rich in Growth Factor (PRGF®) in Alveolar Ridge Preservation After Simple Exodontia in the Anterior Region of Maxilla.

Dental Implantation

Spain
Fundación Eduardo Anitua

Recruiting

Randomized and Controlled Clinical Trial to Evaluate Bacterial Adhesion on Multi-Im® Transepithelial Components

Biofilm Formation

Spain
Edwards Lifesciences

Not yet recruiting

ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral

Mitral Regurgitation | Mitral Valve Disease | Mitral Stenosis
Edwards Lifesciences

Recruiting

ALTERRA Post-Approval Study

Tetralogy of Fallot | Pulmonary Valve Insufficiency | Pulmonary Regurgitation | RVOT Anomaly | Complex Congenital Heart Defect

United States, Israel
Edwards Lifesciences

Recruiting

COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

Pulmonary Valve Insufficiency | Complex Congenital Heart Defect | Dysfunctional RVOT Conduit | Pulmonary Valve Degeneration

United States
Edwards Lifesciences

Active, not recruiting

Transcatheter Repair of Tricuspid Regurgitation With Edwards PASCAL Transcatheter Valve Repair System (TriCLASP)

Tricuspid Valve Insufficiency

Switzerland, Germany, Greece, Italy
Edwards Lifesciences

Terminated

Hypotension Prediction Index (HPI) SMART-BP Trial

Moderate to High-risk Noncardiac Surgery

United States
Edwards Lifesciences

Completed

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk (PII A)

Symptomatic Severe Aortic Stenosis

United States, Canada
Edwards Lifesciences

Active, not recruiting

Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients

Mitral Valve or Aortic Valve Replacement

China
Edwards Lifesciences

Completed

CE Mark Study for the Harpoon Medical Device (TRACER)

Mitral Valve Insufficiency | Mitral Valve Prolapse | Mitral Valve Regurgitation

Italy, United Kingdom
Edwards Lifesciences

Active, not recruiting

The SAPIEN 3 Ultra System in Intermediate Risk Patients With Symptomatic, Severe Aortic Stenosis

Aortic Valve Stenosis

Canada, United Kingdom
Edwards Lifesciences

Terminated

Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE) (ACTIVE)

Mitral Regurgitation | Mitral Insufficiency | Functional Mitral Regurgitation

United States
Edwards Lifesciences

Enrolling by invitation

RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65 (RESILIENCE)

Aortic Valve Replacement

United States
Edwards Lifesciences

Active, not recruiting

PARTNER 3 Trial - Mitral Valve in Valve

Heart Failure | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Disease

United States, Australia, Brazil
Edwards Lifesciences

Active, not recruiting

CENTERA PMCF: Post-Market Follow-up of the CENTERA Transcatheter Heart Valve System

Aortic Valve Stenosis

Denmark, United Kingdom, Netherlands, Spain, Germany, France
Edwards Lifesciences

Completed

China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population

Aortic Stenosis | Aortic Regurgitation | Symptomatic Aortic Stenosis

China
Edwards Lifesciences

Completed

Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON)

Aortic Valve Stenosis | Aortic Valve Stenosis With Insufficiency

Austria, Germany
Edwards Lifesciences

Active, not recruiting

ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent

Tetralogy of Fallot | Pulmonary Disease | Congenital Heart Disease | Pulmonary Regurgitation | Transcatheter Pulmonary Valve Replacement (TPVR)

United States
Edwards Lifesciences

Active, not recruiting

Transcatheter Repair of Tricuspid Regurgitation With Edwards Cardioband TR System Post Market Study (TriBAND) (TriBAND)

Tricuspid Regurgitation | Tricuspid Insufficiency

Germany, Spain, Switzerland
Edwards Lifesciences

Completed

Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System

Tricuspid Valve Regurgitation

United States
Edwards Lifesciences

Active, not recruiting

Edwards Cardioband European Post-Market Study, MiBAND (MiBAND)

Mitral Regurgitation | Mitral Insufficiency | Mitral Repair | Mitral Valve | Annuloplasty | Edwards Cardioband

Switzerland, Germany, Italy
Edwards Lifesciences

Completed

HUDDLE: Heart Health: Understanding & Diagnosing Disease by Leveraging Echocardiograms (HUDDLE)

Heart Diseases | Cardiovascular Diseases

United States
Edwards Lifesciences

Completed

PARTNER II Trial: S3iCAP (PII S3i CAP)

Aortic Stenosis

United States, Canada
Edwards Lifesciences

Completed

PREVAIL-TF: Transfemoral Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe)

Aortic Valve Stenosis

Germany, France, United Kingdom, Belgium
Edwards Lifesciences

Completed

PREVAIL-20J - Transfemoral Placement of 20mm Aortic Balloon Expandable Transcatheter Valve Trial (PREVAIL-20J)

Aortic Valve Stenosis

Japan
Edwards Lifesciences

Completed

PREVAIL-J - Transfemoral & Transapical Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Japan)

Aortic Valve Stenosis

Japan
Edwards Lifesciences

Completed

EDWARDS INTUITY Valve System FOUNDATION Study (FOUNDATION)

Aortic Stenosis | Aortic Valve Disease | Rapid Deployment Valves

Spain, United Kingdom, Austria, Netherlands, Italy, France, Germany, Denmark, Switzerland
Edwards Lifesciences

Terminated

Safety and Performance Study of the Harpoon Mitral Valve Repair System

Mitral Valve Insufficiency | Mitral Valve Prolapse | Mitral Valve Regurgitation

Poland
Edwards Lifesciences

Completed

EDWARDS INTUITY Valve System CADENCE-MIS Study (CADENCE-MIS)

Aortic Stenosis | Aortic Valve Disease

Germany
Edwards Lifesciences

Completed

EDWARDS INTUITY Valve System CADENCE Study (CADENCE)

Aortic Stenosis | Aortic Valve Disease

France
Edwards Lifesciences

Withdrawn

CardiAQ-Edwards™ Transcatheter Mitral Valve Replacement (TMVR) Study (RELIEF)

Mitral Valve Regurgitation

Italy, Canada, Denmark, Switzerland, France, Germany, Netherlands
Edwards Lifesciences

Completed

THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial (PARTNER)

Critical Aortic Stenosis

United States, Canada, Germany
Edwards Lifesciences

Recruiting

ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW II)

Heart Failure

United States
Edwards Lifesciences

Recruiting

ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve

Aortic Stenosis, Severe

United States, Australia, New Zealand, Canada
Edwards Lifesciences

Recruiting

ExplorATory Study oF the EdWards Transcatheter Atrial Shunt System (AlT FloW Germany) (AlT-FloW)

Heart Failure

Germany
Edwards Lifesciences

Recruiting

COMPASSION S3 Post-Approval Study

Pulmonary Valve Insufficiency | Complex Congenital Heart Defect | Dysfunctional RVOT Conduit | Pulmonary Valve Degeneration | Pulmonary Valve; Obstruction

United States
Edwards Lifesciences

Recruiting

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial (CLASP II TR)

Tricuspid Valve Insufficiency | Tricuspid Regurgitation | Tricuspid Valve Disease

United States, Canada
Edwards Lifesciences

Recruiting

PARTNER 3 Trial - Aortic Valve-in-Valve

Aortic Stenosis | Aortic Stenosis, Severe

United States, Canada
Edwards Lifesciences

Active, not recruiting

SAPIEN 3 Ultra System PMCF

Aortic Valve Stenosis

Germany, Denmark, Austria, Netherlands, Finland, United Kingdom, Canada, Italy
Edwards Lifesciences

Active, not recruiting

2019-06 TRISCEND Study

Cardiovascular Diseases | Heart Valve Diseases | Tricuspid Valve Regurgitation

United States, Canada, France, Switzerland
Edwards Lifesciences

Active, not recruiting

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Coronary Artery Disease | Heart Failure | Mitral Valve Regurgitation | Mitral Valve Incompetence

Canada, United States, Austria, Germany

Clinical Trials Sponsored by Edgardo Szyld

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations